Advisory Board and Editors Molecular Biology
Blanca B. Landa
EDUCATION:
Ph.D. Agricultural Engineer, Institute of Sustainable Agriculture, CSIC, and University of Cordoba, Cordoba, Spain. July, 1999.
RESEARCH INTERESTS:
Population biology and biogeography of soilborne pathogens and biocontrol angents in the rhizosphere. Integrated control of plant pathogens; Rhizosphere microbial ecology; Biocontrol; Molecular diagnosis; Metagenomic analysis of microbial populations.
B Duncan X Lascelles
After graduating from the veterinary program at the University of Bristol, U.K., with honors, Dr. Lascelles completed a PhD in aspects of pre-emptive/perioperative analgesia at the University of Bristol. After an internship there, he completed his surgical residency at the University of Cambridge, U.K. and then a Fellowship in Oncological Surgery at Colorado State University. He is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University.
Patrizia Lavia
Research Director at Institute of Molecular Biology and Pathology (IBPM), CNR, Rome (Italy). Main research interests:
- control of the cell cycle, mitosis, and the mitotic apparatus in human cells
- origins of genetic instability and cancer
- roles of nuclear transport receptors in nuclear organization and cell division
- signalling by GTPases and kinases
- innovative drug design, drugs targeting the cell cycle
-cellular imaging
Tong Geon Lee
Genetics, Genomics, Bioinformatics, Corn, Tomato, Soybean, Wheat-Rye Translocation
Jack C. Leo
I study bacterial pathogenesis, focusing on autotransporters of Gram-negative bacteria. These proteins are self-contained secretion systems and surface molecules that mediate a number of virulence functions. I aim to understand three aspects of autotransporter-mediated pathogenesis: 1) the mechanisms of virulence functions, 2) the biogenesis of autotransporters and 3) regulation of gene expression. All three are potential sites for intervention to prevent host colonisation and infection.
Liudmila P Leppik
Assistant Director, Frankfurt Initiative for Regenerative Medicine, J.W. Goethe-Universität, Friedrichsheim Orthopedic University Hospital.
Dr. Leppik’s research background is in the fields of molecular biology and virology in Russia and Germany. Specifically her research focused on human genome activity and regulation of gene expression during tumor genesis and development and differentiation. Her current research at FIRM focuses on tissue development and regeneration.
Florian Lesage
Florian Lesage is senior research director at INSERM (French National Health Institute). He is a molecular biologist with extensive experience in ion channel cloning, expression and characterization, in particular in the neurosensory systems. He has authored 15 international patents and >120 publications that have received more than 15,000 citations (http://scholar.google.fr/citations?user=4RXbfuMAAAAJ&hl=fr&oi=ao).
Florian Lesage is the director of the Laboratoire d'Excellence "Ion Channel Science and Therapeutics" (LabEx ICST, www.labex-icst.fr/en).
Zhiming Li
Dr. Zhiming Li is an early career researcher at Columbia University. His primary research focus is on epigenetic inheritance and cancer epigenetics, and his long-term goals are to understand the fundamental mechanisms of epigenetic inheritance and how such mechanisms and epigenetic alterations are involved in tumorigenesis, which eventually would allow him to identify druggable targets for cancer intervention.
Cong-Jun Li
A molecular biologist in the Bovine Functional Genomics Laboratory, Agricultural Research Service, USDA. My research is focused on the interaction of nutrients and epigenomic regulation; analyze histone-DNA interaction in the bovine genome that is responsive to volatile fatty acid modulation to understand the functional roles of histone modification in gene expression regulation, cell cycle regulation, as well as rumen development.
Xing Li
Dr. Xing Li is an Assistant Professor and Associate Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Science Research at Mayo Clinic - voted the best hospital by U.S. News & World Report. Dr. Li completed his PhD in Bioinformatics from The University of Michigan at Ann Arbor, Michigan, USA. Dr. Li also holds a Masters Degree in Biochemistry and Molecular Biology and Bachelors Degree in Microbiology. Dr. Li’s research interests focus on machine learning, bioinformatics, and statistical data mining in large scale data in biomedical research, such as next generation sequencing data (whole genome sequencing, RNA-seq, microarray data), in the file. He has published more than 20 peer-reviewed papers in reputable journals and book chapters in the fields of Bioinformatics and Biostatistics, cancer research, cardiovascular disease, embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) research, and human genomics, genetics and development, and Microbiology. Dr. Li’s publications have been highlighted as Journal Cover Stories, Journal Featured Articles, Highlights Section Papers, Must Read by Faculty 1000, and ESC & iPSC News, etc. Dr. Li has been developing data analysis tools, such as RCircle and PCA3d, etc. Dr. Li is also a member of American Association for Cancer Research (AACR), International Society for Computational Biology (ISCB), American Statistics Association (ASA) and American Heart Association (AHA).
Ning Li
Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.
Chun Liang
Professor in Bioinformatics, Biology Department, Miami University, Ohio, USA